Mirae Asset Global Investments Co., Ltd. Iveric Bio, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$26.24 - $39.63 $124,403 - $187,885	-4,741 Reduced 6.33%	70,191 $2.76 Million
Q1 2023 May 04, 2023	BUY	$18.67 - $24.56 $266,271 - $350,274	14,262 Added 23.51%	74,932 $1.82 Million
Q4 2022 Feb 09, 2023	BUY	$17.24 - $23.95 $137,092 - $190,450	7,952 Added 15.08%	60,670 $1.3 Million
Q3 2022 Nov 10, 2022	BUY	$9.4 - $18.59 $159,095 - $314,635	16,925 Added 47.29%	52,718 $946,000
Q2 2022 Jul 26, 2022	BUY	$9.12 - $18.9 $326,432 - $676,487	35,793 New	35,793 $345,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.